combination of novel agents in cll: is this the final answer?
Published 4 years ago • 2.9K plays • Length 24:17Download video MP4
Download video MP3
Similar videos
-
18:49
use of novel prognostic markers in practice for cll
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
12:34
debate: is it appropriate to treat patients with cll earlier in the era of novel agents? - no
-
15:02
debate: will novel-agent based combination therapy become standard of care for cll? - no
-
27:18
novel treatment options in cll
-
22:47
the sequencing of novel agents: does it matter?
-
14:07
novel agents in the pipeline for cll & lymphoma
-
13:49
roger talks about living with cll
-
21:35
leukemia (leukemia akut dan kronik)
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
7:01
novel frontline combinations with ibrutinib in cll
-
16:24
chemotherapy vs novel agents in young cll patients: is there still a role for chemo?
-
1:01
cll resistance mechanisms in the era of novel agents
-
20:59
targeted inhibition of signal molecules as novel therapy for cll
-
19:42
treatment options for the young cll patient with deletion 17p: do they need a different approach?
-
23:25
velocity vlog: transforming the diagnosis and treatment of cll
-
23:32
what's next in cll?
-
6:30
cll whiteboard #1: introduction & mechanisms of action of bcr signaling inhibitors
-
1:32
novel agent combinations: the future of cll
-
23:41
novel therapeutic approaches in cll
-
20:21
novel agents in elderly cll patients: should the approach be different?